Netflix stock price slides as Warner Bros deal scrutiny tightens

Netflix stock price slides as Warner Bros deal scrutiny tightens

New York, Feb 3, 2026, 18:07 EST — After-hours

  • Netflix shares dipped 3.4% by Tuesday’s close and held steady in after-hours trading
  • Warner Bros’ deal remains in the spotlight amid Senate antitrust scrutiny and an upcoming shareholder vote
  • Investors are focused on the rival tender-offer deadline set for Feb. 20 and a potential vote in March

Netflix shares dropped 3.4% to $79.94 on Tuesday, shedding $2.79 from the previous close as renewed deal scrutiny rattled investors. The stock held steady in after-hours trading.

The key issue centers on Netflix’s plan to acquire Warner Bros Discovery’s streaming and studio assets in a deal worth roughly $82.7 billion. CNBC says shareholders are expected to vote on the deal in March. Meanwhile, Paramount Skydance has pushed its hostile tender offer—aimed straight at shareholders—out to Feb. 20. (Reuters)

In written testimony submitted Tuesday, Ted Sarandos described the deal as mainly vertical, assuring that Netflix will continue releasing Warner Bros films in theaters with 45-day windows. He also highlighted significant subscriber overlap between Netflix and HBO Max, noting the merged company plans to offer discounts to customers subscribing to both. (Securities and Exchange Commission)

Sarandos appeared before the Senate Judiciary Committee chaired by Mike Lee, who cautioned that the deal might reduce competition and pull movies out of theaters. Lee accused Netflix of aiming to be “the one platform to rule them all,” while Sarandos described the battle for viewers’ attention as a “zero-sum game.” (Reuters)

Regulators remain the key wildcard—not just in Washington. The Department of Justice is currently reviewing the deal, while the hearing kept returning to one question: what truly qualifies as a competitor? Subscription streaming, free ad-supported video, or the entire TV screen?

A fresh securities filing raised a subtle warning. Reed Hastings filed a Form 144, signaling he might sell as many as 390,970 Netflix shares linked to stock option exercises. (Securities and Exchange Commission)

Netflix faced resistance beyond the deal, notably in Europe. Berlin-based VDS reported voice actors boycotting the streamer due to a contract clause permitting recordings to be used for AI training. Chairperson Anna-Sophia Lumpe added that Netflix has cautioned German audiences they might have to settle for subtitles rather than dubbed audio if the boycott continues. (Reuters)

Netflix is zeroing in on operations. In its recent quarterly report, it projected 2026 revenue between $50.7 billion and $51.7 billion. The company expects advertising revenue to roughly double this year, with CFO Spencer Neumann estimating ad sales around $3 billion. (Reuters)

The downside is clear. A drawn-out antitrust review, a bitter proxy battle, or a stronger competing offer could stall the deal, leaving Netflix stuck trading as a takeover target rather than a growth stock — headlines dictating the market moves.

Coming up is the Feb. 20 tender-offer deadline from Paramount Skydance, along with the Warner Bros shareholder meeting date, likely set for March. Traders will keep an eye on cues from U.S. and European competition regulators as the review shifts from chatter to concrete action.

Stock Market Today

  • Man Industries (India) Stock Up 14% Despite Modest ROE and Earnings Growth
    February 3, 2026, 8:13 PM EST. Man Industries (India) Limited's stock has surged 14% over the past week on the NSE, stirring investor interest. The company's return on equity (ROE), a key measure of profitability relative to shareholder equity, stands at 8.5%, below the industry average of 13%. Over the last five years, the firm recorded a modest 11% net income growth, trailing the industry's 36% average. Despite weaker financial fundamentals, the stock's recent momentum may reflect investor optimism about other factors like management strategy or low payout ratios. Market watchers should note that earnings growth plays a crucial role in stock valuation, and it remains unclear if this momentum is fully supported by the company's core financial performance.
Eli Lilly stock price drops 4% as Novo outlook jars weight-loss trade ahead of earnings
Previous Story

Eli Lilly stock price drops 4% as Novo outlook jars weight-loss trade ahead of earnings

Texas Instruments stock steadies after-hours as $7 billion Silicon Laboratories talks report surfaces
Next Story

Texas Instruments stock steadies after-hours as $7 billion Silicon Laboratories talks report surfaces

Go toTop